Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 853260 | ISIN: US4781601046 | Ticker-Symbol: JNJ
Tradegate
21.11.24
10:02 Uhr
145,32 Euro
+0,06
+0,04 %
1-Jahres-Chart
JOHNSON & JOHNSON Chart 1 Jahr
5-Tage-Chart
JOHNSON & JOHNSON 5-Tage-Chart
RealtimeGeldBriefZeit
145,08145,7010:03
145,00145,7010:02

Aktuelle News zur JOHNSON & JOHNSON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiJ&J Loses Around $24B in a Month: How to Play the Stock?4
MiJohnson & Johnson, Merck lay off workers in China as local headwinds take a toll 5
MiJohnson & Johnson China begins layoffs amid global reduction of firm's workforce5
MiPureTech Health PLC - PRTC's Seaport Adds Microsoft and J&J Exec to BOD4
MiJ&J, Merck Cut Jobs in China as Local Competition Takes Toll8
DiJ&J, Protagonist's oral psoriasis prospect scores in phase 3 pair, readying case against BMS' Sotyktu24
DiJ&J pill clears skin in two late-stage psoriasis studies6
DiJ&J plots filings after psoriasis drug clears phase 3 test6
JOHNSON & JOHNSON Aktie jetzt für 0€ handeln
DiJ&J China Starts Layoffs Amid New Round of Organizational Restructuring5
MoJ&J's skin disease drug meets main goals of late-stage study3
MoCHMP Recommends Approval Of Janssen-Cilag's Lazcluze + Rybrevant In EU For EGFR-mutated Advanced NSCLC280NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a Johnson & Johnson company (JNJ), Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP)...
► Artikel lesen
MoCHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC2
SaMeridian Investment Counsel Inc. Raises Holdings in Johnson & Johnson (NYSE:JNJ)7
FrJohnson & Johnson (NYSE:JNJ) Trading Up 0.7% - Here's What Happened4
FrCHMP Recommends Janssen-Cilag's Rybrevant + Lazcluze For EGFR-mutated Advanced Non-small Cell Lung Cancer767NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a Johnson & Johnson company, Friday announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
► Artikel lesen
FrThis Is What Whales Are Betting On Johnson & Johnson8
FrFDA Approves Johnson & Johnson's Varipulse Device for AFib3
FrEU regulators endorse meds from BMS, J&J, Eisai and more-plus a clutch of biosims25
FrBiotechs behind J&J-bought Yellow Jersey partner on another immunology asset4
FrEli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program38
Seite:  Weiter >>
898 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
5,1,23